Skip to main content
SpringerLink
Log in

Hematologic aspects of end-stage renal failure

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Summary

Renal dysfunction may give rise to a variety of hematologic disturbances, including anemia, leukocyte dysfunction, and coagulopathy. The anemia of renal failure has been attributed to a relative deficiency of erythropoietin, but absolute deficiencies of iron or folate may also play a role. Other contributing factors include heavy-metal toxicity, blood loss, and a reduction in red cell survival induced by toxic radicals. The treatment of the anemia of renal disease has advanced with the development of recombinant human erythropoietin. At subcutaneous doses of 50–75 IU/kg triweekly in selected patients, normalization of hemoglobin is presently possible. The coagulopathy of renal disease consists of an acquired qualitative platelet defect, best remedied by dialysis but also treated successfully by rHuEPO, cryoprecipitate or DDAVP, and conjugated estrogens. Uremia-induced leukocyte dysfunctions include diminished granulocyte chemotaxis, phagocytosis, and bactericidal activity. Cell-mediated immune defects and hypogammaglobulinemia have also been described. The pathophysiology of the hematologic manifestations of uremia is discussed. Therapeutic recommendations for dealing with anemia, bleeding, and infectious complications of renal failure are described.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Arnaout MA (1993) Cell adhesion molecules in inflammation and thrombosis: status and prospects. Am J Kidney Dis 21:72–76

    Google Scholar 

  2. Bachmann S, Lehir M, Eckardt KU (1993) Colocalization of erythropoietin messenger-RNA and ecto-5′-nucleotidase immunoreactivity in peritubular cells of rat renal cortex indicates that fibroblasts produce erythropoietin. J Histochem Cytochem 41:335–341

    Google Scholar 

  3. Bazilinski N, Shaykh M, Dunea G et al (1985) Inhibition of platelet function by uremic middle molecules. Nephron 40:423–428

    Google Scholar 

  4. Bloom A, Greaves M, Preston FE et al (1986) Evidence against a platelet cyclooxigenase defect in uraemic subjects on chronic haemodialysis. Br J Haematol 62:143–149

    Google Scholar 

  5. Boelaert JR, Cantinieaux BF, Hariga CF, Fondu PG (1990) Recombinant erythropoietin reverses polymorphonuclear granulocyte dysfunction in iron-overloaded dialysis patients. Nephrol Dial Transplant 5:504–507

    Google Scholar 

  6. Carvalho AC (1990) Acquired platelet dysfunction in patients with uremia. Hematol Oncol Clin North Am 1:129–143

    Google Scholar 

  7. Casciato DA, McAdam LP, Kopple JD et al (1984) Immunologic abnormalities in hemodialysis patients: improvement after pyridoxine therapy. Nephron 38:9–16

    Google Scholar 

  8. Castaldi PA, Rozenberg MC, Stewart JH (1966) The bleeding disorders of uraemia. Lancet 2:66

    Google Scholar 

  9. Castillo R, Lozano T, Escolar G, Revert L, Lopez J, Ordinas A (1986) Defective platelet adhesion on vessel subendothelium in uremic patients. Blood 68:337–341

    Google Scholar 

  10. Chandra M, McVivar M, Clemons GK (1988) Pathogenesis of the anemia of chronic renal failure: the role of erythropoietin. Adv Pediatr 35:361–389

    Google Scholar 

  11. Cheigh JS, Kim H, Stenzel KM, Tapia L, Sullivan JF, Stubenbord W, Riggio RR, Rubin AL (1990) Systemic lupus erythematosus in patients with end-stage renal disease: long-term follow-up on the prognosis of patients and the evolution of lupus activity. Am J Kidney Dis 16:189–195

    Google Scholar 

  12. Chew SL, Lins RL, Daelemans R, Zachee P, De Clerck LS, Vermylen J (1992) Are antiphospholipid antibodies clinicallly relevant in dialysis patients? Nephrol Dial Transplant 14:1194–1198

    Google Scholar 

  13. Cledes J, Guillodo MP, Hervé JP, Bourbigot B, Gentric A, Treguer MH, Wehbe B, Le Bihan G (1988) Hemodialysis hypereosinophilia. Contrib Nephrol 62:109–117

    Google Scholar 

  14. D'Haese PC, Clement JP, Elseviers MM, Lamberts LV, Van de Vyver FL, Visser WJ, De Broe ME (1990) Value of serum aluminium monitoring in dialysis patients: a multicenter study. Nephrol Dial Transplant 5:45–53

    Google Scholar 

  15. Dobkin JF, Miller MH, Steigbigel NH (1978) Septicemia in patient on chronic hemodialysis. Ann Intern Med 88:28–33

    Google Scholar 

  16. Domoto DT, Bauman JE, Joinst JH (1991) Combined aspirin and sulfinpyrazone in the prevention of recurrent hemodialysis vascular access thrombosis. Thromb Res 62:737–743

    Google Scholar 

  17. Drüeke TB (1990) Resistance to recombinant human erythropoietin in hemodialysis patients. Am J Nephrol 10 [Suppl 2]:34–39

    Google Scholar 

  18. Eknoyan G, Brown GH (1981) Biochemical abnormalities of platelets in renal failure: evidence for decreased platelet serotonin triphosphatase. Am J Nephrol 1:17–23

    Google Scholar 

  19. Eschbach JW, Adamson JW (1988) Modern aspects of the pathophysiology of renal anemia. Contrib Nephrol 66:63–70

    Google Scholar 

  20. Eschbach JW, Haley NR, Adamson JW (1990) The anemia of chronic renal failure: pathophysiology and effects of recombinant erythropoietin. Contrib Nephrol 78:24–37

    Google Scholar 

  21. Escolar G, Casa A, Bastidi E (1990) Uremic platelets have a functional defect affecting the interaction of von Willebrand factor with glycoprotein IIb-IIIa. Blood 76:1336–1340

    Google Scholar 

  22. Erslev AJ (1991) Erythropoietin. N Engl J Med 324:1339–1344

    Google Scholar 

  23. Fernandez F, Goudable C, Sie P, Ton-That H, Durand D, Sue JM, Boneu B (1985) Low haematocrit and prolonged bleeding time in uraemic patients: effect of red cell transfusions. Br J Haematol 59:139–148

    Google Scholar 

  24. Gafter U, Bessler H, Malachi T, Zevin D, Djaldetti M, Levi J (1987) Platelet count and thrombopoietic activity in patients with chronic renal failure. Nephron 45:207–210

    Google Scholar 

  25. Goldberg MA, Dunning SP, Bunn HF (1988) Regulation of the erythropoietin gene: evidence that the oxygen sensor is a heme protein. Science 242:1412–1415

    Google Scholar 

  26. Goldblum SE, Reed WP (1980) Host defenses and immunologic alterations associated with chronic hemodialysis. Ann Intern Med 93:597–613

    Google Scholar 

  27. Greene WH, Ray C, Mauer SM, Quie PG (1976) The effect of hemodialysis on neutrophil chemotactic responsiveness. J Lab Clin Med 88:971–974

    Google Scholar 

  28. Grützmacher P, Ehmer B, Messinger D (1989) Effect of aluminum overload on the bone marrow response to recombinant erythropoietin. Contrib Nephrol 76:315–323

    Google Scholar 

  29. Gura V, Creter D, Levi J (1979) Elevated thrombocyte calcium in uremia and its correction by 1α(OH) vitamin D treatment. Nephron 11:181–189

    Google Scholar 

  30. Guzzo J, Niewiarowski S, Musial J, et al (1980) Secreted platelet proteins with antiheparin and mitogenic activities in chronic renal failure. J Lab Clin Med 96:102–113

    Google Scholar 

  31. Hällgren H, Fjellström KE, Häkansson L, Venge P (1979) Kinetic studies of phagocytosis. II. The serum-independent uptake of IgG-coated particles by polymorphonuclear leukocytes from uremic patients on regular dialysis treatment. J Lab Clin Med 94:64–68

    Google Scholar 

  32. Hammerschmidt DE, Goldberg R, Raij L, Kay NE (1985) Leukocyte abnormalities in renal failure and hemodialysis. Semin Nephrol 2:91–103

    Google Scholar 

  33. Himmelfarb J, Zaoui P, Hakim R (1992) Modulation of granulocyte LAM-1 and MAC-1 during dialysis — a prospective, randomized controlled tial. Kidney Int 41:388–395

    Google Scholar 

  34. Hirabayashi Y, Kobayashi T, Nishikawa A, Okazaki H, Aoki T, Takaya J, Kobayashi T (1988) Oxidative metabolism and phagocytosis of polymorphonuclear leukocytes in patients with chronic renal failure. Nephron 49:305–312

    Google Scholar 

  35. Horowitz HI, Stein IM, Cohen BD (1970) Further studies on the platelet-inhibiting effect of guanidino-succinic acid and its role in uremic bleeding. Am J Med 49:336–345

    Google Scholar 

  36. Hübel E, Kiefer T, Weber J, Mettano T, Kuhlmann U (1991) In vivo effect of 1,25-dihydroxyvitamin D3 on phagocyte function in hemodialysis patients. Kidney Int 40:927–933

    Google Scholar 

  37. Jubelirer SJ (1985) Hemostatic abnormalities in renal disease. Am J Kidney Dis V:219–225

    Google Scholar 

  38. Keane WF, Shapiro FL, Raij L (1977) Incidence and type of infections occurring in 445 chronic hemodialysis patients. Trans Am Soc Artif Intern Organs 23:41–47

    Google Scholar 

  39. Keane WF, Raij LR (1983) Host defenses and infectious complications in maintenance hemodialysis patients. In: Drukker W, Parson FM, Maher JF (eds) Replacment of renal function by dialysis, 2nd edn. Martinus Nijhoff, Boston, pp 646–658

    Google Scholar 

  40. Kimmel PL, Watkins DW, Teller EB, Khanna R, Dosa S, Phillips TM (1988) Zinc balance in combined zinc deficiency and uremia. Kidney Int 33:1091–1099

    Google Scholar 

  41. Koch KM, Shaldon S, Bingel M, et al (1986) Plasma interleukin-1 levels are raised in end-stage renal disease patients on long-term hemodialysis (Abstract 80A). Am Soc Nephrol, Washington, DC, December

    Google Scholar 

  42. Köhler H, Arnold W, Renschin G, Dormeyer HH, Meyer zum Büschenfelde KH (1984) Active hepatitis B vaccination of dialysis patients and medical staff. Kidney Int 25:124–128

    Google Scholar 

  43. Komarnicki M, Twardowski T (1987) Platelet glycoprotein concentrations in patients with chronic uraemia. Folia Haematol (Leipz) 114:642–645

    Google Scholar 

  44. Livio M, Mannucci PM, Vigamo G, Mingardi G, Lombardi R, Mecca G, Remuzzi G (1986) Conjugated estrogens for the management of bleeding associated with renal failure. N Engl J Med 315:731–735

    Google Scholar 

  45. Livio M, Marchesi D, Remuzzi G, Gotti E, Mecca G, de Gaetano G (1982) Uramic bleeding: role of anaemia and beneficial effect of red cell transfusions. Lancet 2:1013–1015

    Google Scholar 

  46. Liu Y, Kosfeld RE, Marcum SG (1984) Treatment of uraemic bleeding with conjugated oestrogen. Lancet 2:887–889

    Google Scholar 

  47. Lucchi L, Cappelli G, Acerbi MA, Spattini A, Lusvarghi E (1989) Oxidative metabolism of polymorphonuclear leukocytes and serum opsonic activity in chronic renal failure. Nephron 51:44–50

    Google Scholar 

  48. Luger A, Kovarik J, Stummvoll H, Urbanska A, Luger TA (1987) Blood-membrane interaction in hemodialysis leads to increased cytokine production. Kidney Int 32:84–88

    Google Scholar 

  49. Maderazo EG, Woronick CL, Albano SD, Breaux SP, Pock RM (1986) Inappropriate activation, deactivation, and probable autooxidative damage as a mechanism of neutrophil locomotory defect. J Infect Dis 154:471–477

    Google Scholar 

  50. Mannucci PM, Remuzzi G, Pusineri F, et al (1983) Deamino-8D-arginine vasopressin shortens the bleeding time in uremia. N Engl J Med 308:8–12

    Google Scholar 

  51. Mattern WD, Hak LJ, Lamanna RW, Teasle KM, Laffell MS (1982) Malnutrition, altered immune function, and risk of infection in maintenance hemodialysis patients. Am J Kidney Dis 1:206–218

    Google Scholar 

  52. Maxwell PH, Osmond MK, Pugh CW, Heryet A, Nicholls LG, Tan CC, Doe BG, Ferguson DJP, Johnson MH, Ratcliffe PJ (1993) Identification of the renal erythropoietin-producing cells using transgenic mice. Kidney Int 44:1149–1162

    Google Scholar 

  53. Meuer SC, Hauer M, Kurz P, Meyer zum Büschenfelde KH, Köhler H (1989) Low-dose interleukin-2 induces systemic immune responses against HbsAg in immunodeficient nonresponders to hepatitis B vaccination. Lancet 1:15–18

    Google Scholar 

  54. Modai D, Sagi DB, Maor J (1980) Effect of levamisole on skin reactions to DNCB in chronically dialyzed patients. Nephron 25:280–282

    Google Scholar 

  55. Pedersen JO, Knudson F, Nielsen AH, Grummet N (1987) The ability of uremic serum to induce neutrophil chemotaxis in relation to hemodialysis. Blood Purif 5:24–28

    Google Scholar 

  56. Port FK, Ragheb NE, Schwartz AG, Hawthorne VM (1989) Neoplasms in dialysis patients: a population-based study. Am J Kidney Dis 14:119–123

    Google Scholar 

  57. Rabiner SF, Molinas F (1970) The role of phenol and phenolic acids on the thrombocytopathy and defective platelet aggregation of patients with renal failure. Am J Med 49:346–351

    Google Scholar 

  58. Rao AK (1986) Uraemic platelets. Lancet 1:913–914

    Google Scholar 

  59. Remuzzi G, Benigni A, Dodessini P (1981) Parathyroid hormone inhibits human platelet function. Lancet 1:132–223

    Google Scholar 

  60. Remuzzi G, Livio M, Marchiaro G, Mecca G, de Gaetano G (1978) Bleeding in renal failure: altered platelet function in chronic uraemia only partially corrected by haemodialysis. Nephron 22:347–353

    Google Scholar 

  61. Ringoir S, Van Landschoot N, De Smet R (1980) Inhibition of phagocytosis by a middle molecular fraction from ultrafiltrate. Clin Nephrol 13:109–112

    Google Scholar 

  62. Ritchey EE, Wallin JD, Shah SV (1981) Chemiluminescence and superoxide anion production by leukocytes from chronic hemodialysis patients. Kidney Int 19:349–358

    Google Scholar 

  63. Rodger LB (1992) Acquired platelet function defects in perplexing thrombotic and hemorrhagic disorders. Hematol Oncol Clin North Am 2:1203–1228

    Google Scholar 

  64. Ruiz P, Gomez F, Schreiber AD (1990) Impaired function of macrophage Fc, receptors in end-stage renal disease. New Engl J Med 11:717–722

    Google Scholar 

  65. Sennesael JJ, Van Der Niepen P, Verbeelen DL (1991) Treatment with recombinant human erythropoietin increases antibody titers after hepatitis B vaccination in dialysis patients. Kidney Int 40:121–128

    Google Scholar 

  66. Singal DP, Ludwin D, Blajchman MA (1985) Blood transfusion and renal transplantation. Br J Haematol 61:595–602

    Google Scholar 

  67. Sinzinger H, Leither C (1978) Eicosanoids of platelets and vascular wall in chronic renal insufficiency. Am J Nephrol 7:212–220

    Google Scholar 

  68. Siriwatratananonta P, Sinsakul V, Stern K, Slavin RG (1978) Defective chemotaxis in uremia. J Lab Clin Med 92:402–407

    Google Scholar 

  69. Solomkin JS, Jenkins MK, Nelson RD, Chenoweth D, Simmons RL (1981) Neutrophil dysfunction in sepsis. II. Evidence for the role of complement activation products in cellular deactivation. Surgery 90:282–286

    Google Scholar 

  70. Stewart JH, Castaldi PA (1967) Uraemic bleeding: a reversible platelet defect corrected by dialysis. Q J Med 36:409–423

    Google Scholar 

  71. Van der Meer JWM (1988) Defects in host-defense mechanisms. In: Rubin RH, Young LS (eds) Clinical approach to infection in the compromised host, 2nd edn. Plenum Medical, New York, pp 41–73

    Google Scholar 

  72. Van Geet C, Hauglustaine D, Verresen L, Vanrusselt M, Vermylen J (1989) Haemostatic effects of recombinant human erythropoietin in chronic haemodialysis patients. Thromb Haemost 61:117–121

    Google Scholar 

  73. Vanholder R, Ringoir S, Dhondt A, Hakim R (1991) Phagocytosis in uremic and hemodialysis patients: a prospective and cross-sectional study. Kidney Int 39:320–327

    Google Scholar 

  74. Vlacoyannis J, Schoeppe W (1982) Adenylate cyclase activity and cAMP content of human platelets in uraemia. Eur J Clin Invest 12:379–439

    Google Scholar 

  75. Wardle EN, Williams R (1980) Polymorph leukocyte function in uremia and jaundice. Acta Haematol 64:157–164

    Google Scholar 

  76. Ware AJ, Clark BA, Smith M, Salzman EW (1988) Abnormalities of cytoplasmic Ca++ in platelets from patients with uremia. Blood 73:172–176

    Google Scholar 

  77. Windus DW, Stokes TJ, Julian BA, Fenves AZ (1987) FatalRhizopus infections in hemodialysis patients recieving deferoxamine. Ann Intern Med 107:678–680

    Google Scholar 

  78. Winearls CG, Pippard MJ, Downing MR, Oliver DO, Reid C, Cotes PM (1986) Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic hemodialysis. Lancet 2:1175–1178

    Google Scholar 

  79. Winkelmann M, Dorr U, Pfitzer P et al (1986) Is lower ploidy megakaryocytes another reason for uremic thrombocytopathy? Klin Wochenschr 64:540–544

    Google Scholar 

  80. Winter M, Seghatchian MJ, Cameron JS (1983) An abnormal factor VIII molecule in uremia? Lancet 1:1112

    Google Scholar 

  81. Zachée P, Emonds MP, Goossens W, Daelemans R, Lins RL, Boogaerts MA (1988) Erythrocyte deformability and oxidative sensitivity in hemodialysis patients. Clin Hemorheol 8:439–443

    Google Scholar 

  82. Zachée P, Emonds MP, Lins RL, Boogaerts MA (1988) Red blood cells, the scavengers for toxic free radicals during haemodialysis. Nephrol Dial Transplant 4:104–105

    Google Scholar 

  83. Zachée P, Normohamed MT, Daelemans R, Stevens P, Cate JW, Hoek JA, Lins RL (1991) Efficacy and safety of low-molecular-weight heparin versus unfractionated heparin in 100 chronic haemodialysis patients. (Abstract no 5) General Meeting of the Belgian Hematological Society

Download references

Author information

Authors and Affiliations

  1. Department of Hematology, Universitair Ziekenhuis Gasthuisberg, Herestraat 49, B-3000, Leuven, Belgium

    P. Zachée & M. A. Boogaerts

  2. Center for Molecular and Vascular Biology, University of Leuven, Leuven, Belgium

    J. Vermylen

Authors
  1. P. Zachée
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Vermylen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. A. Boogaerts
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zachée, P., Vermylen, J. & Boogaerts, M.A. Hematologic aspects of end-stage renal failure. Ann Hematol 69, 33–40 (1994). https://doi.org/10.1007/BF01757345

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01757345

Key words

Search

Navigation